Extracorporeal photochemotherapy in patients with steroid‐dependent Crohn’s disease: a prospective pilot study
Open Access
- 27 September 2001
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (9) , 1313-1322
Abstract
Background: Extracorporeal photochemotherapy has been proven effective in selected T‐cell mediated diseases.Aim: To evaluate the safety and efficacy of extracorporeal photochemotherapy in patients with steroid‐dependent Crohn’s disease by an open, monocentric trial in three phases of 24 weeks each.Methods: In phase 1 standardized steroid tapering was initiated in patients with a history of steroid‐dependent Crohn’s disease. Those with a prospectively evaluated maintenance dose of at least 10 mg/day prednisolone continued steroid‐withdrawal under the application of extracorporeal photochemotherapy in phase 2. The duration of remission or response was followed during phase 3. Colonic tissue bioptically obtained before and after extracorporeal photochemotherapy was studied by immunofluorescence microscopy for the presence of photoadduct positive cells.Results: Out of 24 patients included in phase 1, 10 entered phase 2 for extracorporeal photochemotherapy. Four subjects achieved remission and four others response. Significant reductions in serum C‐reactive protein levels and intestinal permeability were measured, as well as increases in quality of life and plasma adrenocorticotropic hormone levels. No major side‐effects were observed. Remission remained stable in three out of four patients during phase 3. In three patients, positive nuclear stainings of photoadducts were detected in colonic mononuclear cells after extracorporeal photochemotherapy.Conclusions: Extracorporeal photochemotherapy represents a safe steroid‐sparing approach in patients with Crohn’s disease and is associated with intestinal homing of photopheresed cells.Keywords
This publication has 31 references indexed in Scilit:
- Treatment of Peripheral Blood Mononuclear Cells with 8-Methoxypsoralen plus Ultraviolet A Radiation Induces a Shift in Cytokine Expression from a Th1 to a Th2 ResponseJournal of Investigative Dermatology, 2001
- Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP)Bone Marrow Transplantation, 1997
- Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12Nature Genetics, 1996
- T cells in inflammatory bowel disease: protective and pathogenic rolesImmunity, 1995
- Specific Suppression of Lupus-Like Graft-Versus-Host Disease Using Extracorporeal Photochemical Attenuation of Effector LymphocytesJournal of Investigative Dermatology, 1995
- Parenteral administration of 8-methoxypsoralen in photopheresisJournal of the American Academy of Dermatology, 1993
- Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A Pilot studyArthritis & Rheumatism, 1992
- Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated LymphocytesJournal of Investigative Dermatology, 1990
- 8-Methoxypsoralen-DNA Adducts in Patients Treated with 8-Methoxypsoralen and Ultraviolet A LightJournal of Investigative Dermatology, 1989
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987